Again from Ganjapreneur

…. according to an Australian Journal of Pharmacy report. Both drugs are being considered as cancer therapies.

NanaBis will be tested in advanced stage cancer patients with intractable pain. The product, which contains both THC and CBD, is administered using Medlab’s patented nanoparticle spray NanoCelle, which is sprayed on the inside of the cheek for quicker absorption into the blood stream.

The trial aims to determine the efficacy, safety, and tolerability of the of the drug and if it is approved under the Therapeutic Goods Administration Special Access Scheme – required in order for Australians to access cannabis-based medicines – it would be prescribed by specialist doctors.

Australian Firm Set to Trial Two Cannabis-Derived Drugs